Findings

What do systematic reviews say?

1 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Failure to induce endoscopic remission · patients with induction of remission in ulcerative colitis

Etrolizumab showed no clear difference in failure to enter endoscopic remission at week 6 compared with placebo (moderate certainty).

2 findings from 1 review

Etrolizumab for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.98 [0.9, 1.06]
1 study · 119 participants
Moderate
Etrolizumab for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.92 [0.85, 1]
1 study · 119 participants
Moderate